DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Mankind Pharma Limited — Outcome of Board Meeting

NSE 1 hr ago·26 Oct 2026, 9:37 am

Mankind Pharma

Mankind Pharma Limited held a board meeting and subsequently filed its financial results for the quarter ended September 30, 2026 with the exchange. The filing includes the company's earnings, balance sheet and cash flow statements for that period.

For investors, the disclosed numbers give insight into the firm's recent performance, profitability trends and any changes in its capital structure. It also confirms compliance with regulatory reporting requirements, which can affect market perception and stock liquidity.

Going forward, market participants will likely focus on management commentary accompanying the results, any guidance for the next quarter, and upcoming events such as the annual general meeting or product launches that could influence future earnings.